MarketCap
Facebook
X
TelegramAnnual report 2023
added 03-06-2024
Endo International plc P/CF Ratio 2011-2026 | ENDP
Annual P/CF Ratio Endo International plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.157 | 0.253 | 2.13 | 4.09 | 37.3 | 11.8 | 3.62 | 7.18 | -193 | 48.6 | 40.1 | 5.58 | 6.66 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 48.6 | -193 | -1.99 |
P/CF Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-1.75 | - | 7.5 % | $ 6.35 M |  USA |
 |
Cronos Group
CRON
|
-20.4 | $ 2.58 | 1.98 % | $ 1.37 B |  Canada |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.694 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-3.28 | - | - | $ 754 M | USA |
 |
Assertio Holdings
ASRT
|
-2.67 | $ 19.26 | 0.26 % | $ 123 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.135 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-7.12 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
-8.43 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-15.3 | - | - | $ 2.06 B |  France |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-2.09 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-2.07 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
3.28 | $ 5.41 | 1.12 % | $ 1.97 B | Canada |
 |
OrganiGram Holdings
OGI
|
-13.3 | $ 1.38 | - | $ 402 M | Canada |
 |
Aurora Cannabis
ACB
|
-4.34 | $ 3.44 | - | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
-0.857 | $ 1.02 | 2.0 % | $ 110 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-145 | $ 3.1 | -2.21 % | $ 43.6 M | USA |
 |
Catalent
CTLT
|
40.5 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-0.923 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
6.7 | - | -39.89 % | $ 27.7 M | USA |
 |
Evolus
EOLS
|
-6.42 | $ 4.16 | 3.23 % | $ 268 M | USA |
 |
Emergent BioSolutions
EBS
|
-0.673 | $ 8.1 | -1.58 % | $ 415 M | USA |
 |
Evoke Pharma
EVOK
|
-0.449 | - | - | $ 36.6 M | USA |
 |
Harrow Health
HROW
|
44.1 | $ 35.13 | -0.51 % | $ 1.29 B | USA |
 |
Jupiter Wellness
JUPW
|
-1.95 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
0.647 | - | 1.15 % | $ 7.11 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-0.0334 | - | - | $ 193 M | Canada |
 |
OptiNose
OPTN
|
-9.33 | - | - | $ 1.08 B | USA |
 |
Organogenesis Holdings
ORGO
|
29.2 | $ 2.24 | - | $ 295 M | USA |
 |
Pacira BioSciences
PCRX
|
6.22 | $ 22.27 | -1.89 % | $ 1.03 B | USA |
 |
PetIQ
PETQ
|
6.4 | - | 1.64 % | $ 400 M | USA |
 |
Sundial Growers
SNDL
|
-0.00572 | $ 1.34 | -1.47 % | $ 3.37 M | Canada |
 |
PLx Pharma
PLXP
|
-3.68 | - | -27.8 % | $ 2.56 M | USA |
 |
ProPhase Labs
PRPH
|
4.57 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-16.8 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-133 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-5.39 | $ 6.9 | -1.29 % | $ 272 M | USA |
 |
Rockwell Medical
RMTI
|
-51.3 | $ 0.96 | 0.84 % | $ 34.5 M | USA |
 |
SCYNEXIS
SCYX
|
-7.18 | $ 0.92 | 3.28 % | $ 45.9 M | USA |
 |
Solid Biosciences
SLDB
|
-3.99 | $ 7.74 | 3.34 % | $ 677 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-41.6 | $ 2.33 | -1.9 % | $ 2.89 M | USA |
 |
Tilray
TLRY
|
151 | $ 6.66 | 1.68 % | $ 4.12 B | Canada |
 |
Veru
VERU
|
-4.98 | $ 2.4 | 4.8 % | $ 324 M | USA |
 |
Viatris
VTRS
|
6.34 | $ 13.41 | -0.22 % | $ 16.1 B | USA |
 |
cbdMD
YCBD
|
-4.77 | $ 0.73 | -0.4 % | $ 3.15 M | USA |
 |
Zomedica Corp.
ZOM
|
-8.59 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.815 | - | - | $ 55.5 M | USA |
 |
Tricida
TCDA
|
-2.56 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
18.5 | $ 0.61 | -2.94 % | $ 2.62 M |  China |
 |
TherapeuticsMD
TXMD
|
-2.79 | $ 2.2 | 10.0 % | $ 25.5 M | USA |